Stay updated on Nivolumab Ipilimumab Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Gastric Cancer Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.9%
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference2%
- Check39 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check46 days agoChange DetectedThe page has undergone significant updates, including the removal of outdated clinical stage information and the addition of new clinical stage classifications for gastric cancer, reflecting the latest version of the AJCC guidelines. Additionally, the revision date has been updated to 2025.SummaryDifference15%
Stay in the know with updates to Nivolumab Ipilimumab Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Gastric Cancer Clinical Trial page.